Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Bionano Genomics Inc (NASDAQ: BNGO) closed at $0.96 in the last session, down -4.01% from day before closing price of $1.00. In other words, the price has decreased by -$4.01 from its previous closing price. On the day, 0.7 million shares were traded. BNGO stock price reached its highest trading level at $1.02 during the session, while it also had its lowest trading level at $0.9511.
Ratios:
We take a closer look at BNGO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.40. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on January 05, 2023, initiated with a Sector Outperform rating and assigned the stock a target price of $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 13 ’23 when Mamuszka Hannah bought 65,789 shares for $0.76 per share. The transaction valued at 50,000 led to the insider holds 65,789 shares of the business.
Holmlin R. Erik bought 15,000 shares of BNGO for $9,639 on May 16 ’23. The President and CEO now owns 806,474 shares after completing the transaction at $0.64 per share. On May 12 ’23, another insider, Stewart Christopher P., who serves as the Chief Financial Officer of the company, bought 50,000 shares for $0.67 each. As a result, the insider paid 33,415 and bolstered with 281,373 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BNGO now has a Market Capitalization of 63948528 and an Enterprise Value of 64956812. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.77 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at 1.799 whereas that against EBITDA is -0.517.
Stock Price History:
Over the past 52 weeks, BNGO has reached a high of $8.20, while it has fallen to a 52-week low of $0.71. The 50-Day Moving Average of the stock is -5.66%, while the 200-Day Moving Average is calculated to be -52.54%.
Shares Statistics:
According to the various share statistics, BNGO traded on average about 1.44M shares per day over the past 3-months and 847870 shares per day over the past 10 days. A total of 66.86M shares are outstanding, with a floating share count of 66.14M. Insiders hold about 1.07% of the company’s shares, while institutions hold 10.00% stake in the company. Shares short for BNGO as of 1713139200 were 5357106 with a Short Ratio of 3.71, compared to 1710460800 on 5474835. Therefore, it implies a Short% of Shares Outstanding of 5357106 and a Short% of Float of 8.77.
